Onconetix, Inc. Payments of Debt Issuance Costs
Onconetix, Inc. (ONCO) reported Payments of Debt Issuance Costs of $205.09 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-10-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2023-10-20
- Onconetix, Inc. payments of debt issuance costs for the quarter ending 2023-06-30 was $189.59K, a 309.45% increase year-over-year.
- Onconetix, Inc. payments of debt issuance costs for the quarter ending 2023-03-31 was $15.50K, a 210.00% increase year-over-year.
- Onconetix, Inc. payments of debt issuance costs for the quarter ending 2022-09-30 was $0.00.
- Onconetix, Inc. payments of debt issuance costs for the quarter ending 2022-06-30 was $46.30K.
- Onconetix, Inc. payments of debt issuance costs for fiscal 2021 was $334.19K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2023-06-30 | $189.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-20 | $205.09K 10-Q · filed 2023-10-20 | ||
| 2023-03-31 | $15.50K 10-Q · filed 2023-05-12 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $46.30K derived: sum of 2 quarters · filed 2023-10-20 | $51.30K 10-Q · filed 2022-11-14 | $188.52K derived: sum of 4 quarters · filed 2023-10-20 |
| 2022-06-30 | $46.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-20 | $51.30K 10-Q · filed 2023-10-20 | $188.52K derived: sum of 3 quarters · filed 2023-10-20 | |
| 2022-03-31 | $5.00K 10-Q · filed 2023-05-12 | $142.21K derived: sum of 2 quarters · filed 2023-05-12 | ||
| 2021-12-31 | $137.21K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $334.19K 10-K · filed 2023-03-09 | ||
| 2021-09-30 | $196.97K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |